Cargando…
LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse Model
The prototype J-LEAPS T cell vaccine for HER-2/neu breast cancer (J-HER) consists of the murine HER-2/neu(66–74) H-2(d) CD8 T cell epitope covalently attached through a triglycine linker to the J-immune cell binding ligand (ICBL) (human β2 microglobulin(38–50) peptide). The J-ICBL was chosen for its...
Autores principales: | Rosenthal, Ken S., Stone, Sarah, Koski, Gary, Zimmerman, Daniel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385252/ https://www.ncbi.nlm.nih.gov/pubmed/28459074 http://dx.doi.org/10.1155/2017/3613505 |
Ejemplares similares
-
J‐LEAPS peptide and LEAPS dendritic cell vaccines
por: Rosenthal, Ken S., et al.
Publicado: (2012) -
Vaccination by Two DerG LEAPS Conjugates Incorporating Distinct Proteoglycan (PG, Aggrecan) Epitopes Provides Therapy by Different Immune Mechanisms in a Mouse Model of Rheumatoid Arthritis
por: Zimmerman, Daniel H., et al.
Publicado: (2021) -
Breast Cancer and Her-2/Neu
por: Sherwood, Roy
Publicado: (2005) -
HER-2/neu diagnostics in breast cancer
por: Carney, Walter P, et al.
Publicado: (2007) -
The Clinical Importance of the Heterogeneity of HER2 neu
por: Davila, Enrique, et al.
Publicado: (2010)